These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10485309)

  • 1. Outcome predictors in pregnant opiate and polydrug users.
    McCarthy JE; Siney C; Shaw NJ; Ruben SM
    Eur J Pediatr; 1999 Sep; 158(9):748-9. PubMed ID: 10485309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction.
    Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M
    J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
    Dryden C; Young D; Hepburn M; Mactier H
    BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn birth-weight of pregnant women on methadone or buprenorphine maintenance treatment: A national contingency management approach trial.
    Peles E; Sason A; Schreiber S; Adelson M
    Am J Addict; 2017 Mar; 26(2):167-175. PubMed ID: 28191917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009.
    Welle-Strand GK; Skurtveit S; Tanum L; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Eur Addict Res; 2015; 21(5):253-61. PubMed ID: 25967268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance agonist treatments for opiate dependent pregnant women.
    Minozzi S; Amato L; Vecchi S; Davoli M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006318. PubMed ID: 18425946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone maintenance in pregnancy: consequences to care and outcome.
    Edelin KC; Gurganious L; Golar K; Oellerich D; Kyei-Aboagye K; Adel Hamid M
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):399-404. PubMed ID: 3347426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies.
    Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service.
    Buckley V; Razaghi A; Haber P
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):464-70. PubMed ID: 23550533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between maternal use of heroin and methadone and infant birth weight.
    Hulse GK; Milne E; English DR; Holman CD
    Addiction; 1997 Nov; 92(11):1571-9. PubMed ID: 9519499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C in pregnancy.
    Berkley EM; Leslie KK; Arora S; Qualls C; Dunkelberg JC
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):304-10. PubMed ID: 18669727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal nonnarcotic substance abuse during pregnancy: effects on infant development.
    Chasnoff IJ; Schnoll SH; Burns WJ; Burns K
    Neurobehav Toxicol Teratol; 1984; 6(4):277-80. PubMed ID: 6514088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal use of heroin and methadone and infant birth weight.
    MacQueen AR
    Addiction; 1998 Sep; 93(9):1433-4. PubMed ID: 9926549
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between patterns of maternal substance use and infant birth weight, length, and head circumference.
    Shankaran S; Das A; Bauer CR; Bada HS; Lester B; Wright LL; Smeriglio V
    Pediatrics; 2004 Aug; 114(2):e226-34. PubMed ID: 15286261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal methadone dose and neonatal withdrawal.
    Berghella V; Lim PJ; Hill MK; Cherpes J; Chennat J; Kaltenbach K
    Am J Obstet Gynecol; 2003 Aug; 189(2):312-7. PubMed ID: 14520184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance in pregnancy: a reappraisal.
    Brown HL; Britton KA; Mahaffey D; Brizendine E; Hiett AK; Turnquest MA
    Am J Obstet Gynecol; 1998 Aug; 179(2):459-63. PubMed ID: 9731853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis.
    Lutiger B; Graham K; Einarson TR; Koren G
    Teratology; 1991 Oct; 44(4):405-14. PubMed ID: 1835806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.